Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 3
2009 5
2010 4
2011 5
2012 4
2013 10
2014 6
2015 4
2016 9
2017 4
2018 4
2019 4
2020 5
2021 6
2022 8
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

75 results
Results by year
Filters applied: . Clear all
Page 1
Correction to: Surgery due to mechanical bowel obstruction in relapsed ovarian cancer: clinical and surgical results of a bicentric analysis of 87 patients.
Armbrust R, Chekerov R, Sander S, Biebl M, Chopra S, Krell J, Rinne N, Nixon K, Fotopoulou C, Sehouli J. Armbrust R, et al. Among authors: chekerov r. Arch Gynecol Obstet. 2022 Jul;306(1):291-292. doi: 10.1007/s00404-021-06322-1. Arch Gynecol Obstet. 2022. PMID: 34807282 Free PMC article. No abstract available.
Ten years of live surgical broadcast at Charité-MAYO conferences (2010-2019): a systematic evaluation of the surgical outcome.
Altmann J, Chekerov R, Fotopoulou C, Muallem MZ, du Bois A, Cliby W, Dowdy S, Podratz K, Lichtenegger W, Camara O, Tunn R, Cibula D, Kuemmel S, Scambia G, Vergote I, Chiantera V, Pietzner K, Inci MG, Chopra S, Biebl M, Neymeyer J, Blohmer JU, Sehouli J. Altmann J, et al. Among authors: chekerov r. Int J Gynecol Cancer. 2022 Jun 6;32(6):746-752. doi: 10.1136/ijgc-2021-003173. Int J Gynecol Cancer. 2022. PMID: 35383091
HE4 as a serum biomarker for the diagnosis of pelvic masses: a prospective, multicenter study in 965 patients.
Braicu EI, Krause CL, Torsten U, Mecke H, Richter R, Hellmeyer L, Lanowska M, Müller B, Koch E, Boenneß-Zaloum J, Ames K, Chekerov R, Hasenbein K, Zimmermann M, Mangler M, Chen F, Tauber R, Sehouli J. Braicu EI, et al. Among authors: chekerov r. BMC Cancer. 2022 Jul 30;22(1):831. doi: 10.1186/s12885-022-09887-5. BMC Cancer. 2022. PMID: 35907794 Free PMC article.
Participation of elderly gynecological cancer patients in clinical trials.
Prieske K, Trillsch F, Oskay-Özcelik G, Chekerov R, Bleich C, Oliveira-Ferrer L, Grimm D, Kuerti S, Mueller V, Suling A, Schmalfeldt B, Sehouli J, Mahner S, Woelber L. Prieske K, et al. Among authors: chekerov r. Arch Gynecol Obstet. 2018 Oct;298(4):797-804. doi: 10.1007/s00404-018-4886-2. Epub 2018 Aug 30. Arch Gynecol Obstet. 2018. PMID: 30167853
Predictive biomarker for surgical outcome in patients with advanced primary high-grade serous ovarian cancer. Are we there yet? An analysis of the prospective biobank for ovarian cancer.
Keunecke C, Kulbe H, Dreher F, Taube ET, Chekerov R, Horst D, Hummel M, Kessler T, Pietzner K, Kassuhn W, Heitz F, Muallem MZ, Lang SM, Vergote I, Dorigo O, Lammert H, du Bois A, Angelotti T, Fotopoulou C, Sehouli J, Braicu EI. Keunecke C, et al. Among authors: chekerov r. Gynecol Oncol. 2022 Aug;166(2):334-343. doi: 10.1016/j.ygyno.2022.06.010. Epub 2022 Jun 21. Gynecol Oncol. 2022. PMID: 35738917
Can a morphological description of the peritoneal carcinomatosis in advanced ovarian cancer add prognostic information? Analysis of 1686 patients of the tumor bank ovarian cancer.
Nasser S, Babayeva A, Braicu I, Richter R, Bilir E, Chekerov R, Muallem MZ, Pietzner K, Inci MG, Sehouli J. Nasser S, et al. Among authors: chekerov r. Front Oncol. 2022 Dec 21;12:1014073. doi: 10.3389/fonc.2022.1014073. eCollection 2022. Front Oncol. 2022. PMID: 36620574 Free PMC article.
Genotype-specific high-risk human papillomavirus infections and risk factors for cervical dysplasia in women with human immunodeficiency virus in Germany: results from a single-center cross-sectional study.
Wagner A, Skof AS, Sehouli J, Richter R, Henrich W, von Weizsäcker K, Siedentopf JP, Chekerov R, Kaufmann AM, Rohr I. Wagner A, et al. Among authors: chekerov r. Int J Gynecol Cancer. 2022 Jun 6;32(6):716-723. doi: 10.1136/ijgc-2021-003327. Int J Gynecol Cancer. 2022. PMID: 35354606
Survey on implementation of molecular testing in ovarian cancer and PARP inhibitor: a national North-Eastern German Society of Gynecologic Oncology/Young Academy of Gynecologic Oncology/Arbeitsgemeinschaft Gynäkologische Onkologie intergroup analysis.
Nguyen-Sträuli BD, Baum J, Meyer-Wilmes P, Kreklau A, Buschmann C, El Ouardi N, Fotopoulou C, Hummel M, Chekerov R, Braicu E, Sehouli J, Pietzner K. Nguyen-Sträuli BD, et al. Among authors: chekerov r. Int J Gynecol Cancer. 2022 Jul 27:ijgc-2022-003637. doi: 10.1136/ijgc-2022-003637. Online ahead of print. Int J Gynecol Cancer. 2022. PMID: 35896275
75 results